Apria Home
ChannelsResourcesServicesInsuranceBranch LocatorAbout ApriaCareersHelp
 resources
Community
Health Advisors
Patient Education
Other Sources
Glossaries
Product Manuals
FAQS
News
Electronic CMN
  Search Apria articles:
 
     
 Channels
Cancer
Caregivers
Degenerative Conditions
Diabetes
Heart
Infectious Diseases
Pediatrics
Respiratory
Seniors
Sleep Disorders
 
 
   
  Increase Font Size Decrease Font Size Printer Friendly
 
  Nanoscience unit signs sports licensing agreement for initial 1.5 mln pounds
 
 

LONDON (Thomson Financial) - Nanoscience Inc., said its wholly owned Toumaz Technology Ltd. has signed a new licensing agreement for an initial 1.5 million pounds with a sports-focused business originating in the Far East to develop Toumaz's Sensium brand globally through the sports industry.

The investor in emerging technologies for the healthcare and electronic sectors said 500,000 pounds has just been received and the remainder will be paid within the next six months.

Sensium measures key vital signs, including as heartbeat, body temperature, respiration rate and physical movement on a continuous and real time basis, which can be used by athletes and trainers, Nanoscience said.

The company said under the agreement Sensium will initially be targeted at football and horse racing, and a development programme is currently underway. It said Toumaz also is cultivating independent relationships in the rugby sector. TFN.newsdesk@thomson.com vsr/kf1 COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior

 
  Copyright 2008 AFX News Limited. All Rights Reserved.
 
 
 
Contact Us | Terms & Conditions | Privacy Policy | HIPAA Privacy Notice
 
2008 Apria Healthcare All Rights Reserved.
No duplication of any material herein is authorized without the express consent of Apria Healthcare, Inc.
Please review the Terms and Conditions of this Web site.